Navigation Links
China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Quarter 2008
Date:11/20/2008

ital 6,193,927 6,193,927 Statutory reserves 147,023 147,023 Retained earnings 1,803,494 4,039,337 Accumulated other comprehensive income, foreign currency translation 1,673,832 929,643 Total Stockholders' Equity 9,820,244 11,311,898 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $33,782,797 $35,335,718 China Shenghuo Pharmaceutical Holdings, Inc. Consolidated Statements of Operations and Comprehensive Income (Unaudited) Three Months Ended Six Months Ended June 30, June 30, 2008 2007 2008 2007 Sale of Products $8,591,297 $6,356,217 $14,077,765 $10,683,342 Cost of Products Sold 2,988,119 1,580,478 5,087,581 2,722,176 Gross Profit 5,603,178 4,775,739 8,990,184 7,961,166 Operating Expenses: Selling expense 4,035,573 2,031,590 5,677,075 3,634,414 General and administrative expense 2,714,259 1,388,866 5,181,837 2,362,471 Research and development expense 70,213 2,472 189,189 5,349 Total Operating Expenses 6,820,045 3,422,928 11,048,101 6,002,234 Income (Loss) from Operations (1,216,867) 1,352,811 (2,057,917) 1,958,932 Other Income (Expense): Interest income 1,848 2,804 5,113 9,266 Income from research and development activities 75,588 79,786 338,625 81,004 Interest expense (435,114) (209,458) (691,196) (389,641) Non-operating expenses (65,337) -- (138,482) -- Net Other Expen
'/>"/>
SOURCE China Shenghuo Pharmaceutical Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. ChinaBio(R) Inaugural Partnering Forum Scheduled for June 2009 in Shanghai, China
2. China Documents First Case of Tick-Borne Disease Spread
3. Drug Information Association (DIA) Opens New Office In China
4. China Healthcare Acquisition Corp Agrees to Terminate Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
5. China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009
6. China Bio-Immunity Corporation to Report Third Quarter 2008 Financial Results
7. Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC
8. Measles Initiative Supports Disease Prevention for Children in Chinas Earthquake Zone
9. China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results
10. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
11. China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4 242 million grant aids study of lung cancer in people who never smoked 9305 1 242 million grant aids study of lung cancer in people who never smoked 9305 2 242 million grant aids study of lung cancer in people who never smoked 9305 3Genetic tests advertised directly to the consumer 9302 1Genetic tests advertised directly to the consumer 9302 2Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 1Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 2Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 3Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 4